LISAvienna e-Newsletter 05/2016 – Get Connected
Is this email not displaying correctly?
View it in your browser


e-Newsletter 05/2016

Dear  readers,

Before heading off to your summer holidays, please make sure that you have registered for all relevant events and trade fairs, such as the delegation trip to China and Taiwan. 

Once again, we summarize some interesting opportunities for support. What about preparing proposals for funding and submitting your application to WKW’s innovation award Mercur’16? 

Enjoy our news review below and have a great summer! 



Bionorica to establish sales office in Vienna
Bionorica is a German manufacturer of herbal medicines that uses research and development to provide effective and well-tolerated medicines. The company’s new office in Vienna complements its center for plant research in the Tyrol, which is a partner of the Austrian Drug Screening Institute.
Evercyte and VTU Technology collaborate on the development of recombinant media supplements 
The first conjointly developed recombinant product, Vascular Endothelial Growth Factor 165 (VEGF 165), has been launched, and further targets are in the pipeline. Evercyte’s precise and reproducible in-vitro cell-based assays guarantee the high quality of each production batch.
GMI: Botanic Quest – a smartphone based scavenger hunt for the Botanical Gardens
Recently, the GMI, in collaboration with the Botanical Gardens of the University of Vienna and with financial support from the Vienna Business Agency, released Botanic Quest. This smartphone-based scavenger hunt/quiz allows users to learn about the fascinating world of plants.
Horizon & Ubiquigent enter into collaboration agreement 
Under the terms of the agreement, Horizon’s X-MAN® cell lines have been made available in conjunction with Ubiquigent’s ubiquitin-related drug discovery services. This deal has been negotiated by Horizon’s experts in Vienna.
IMBA: Prevention of genetic breast cancer within reach by using an approved drug
An international team led by researchers at the Austrian Institute of Molecular Biotechnology (IMBA) in Vienna and the University of Maryland School of Medicine in Baltimore discovered that genetically determined breast cancer can be largely prevented by blocking a bone gene. 
MedUni Vienna: Towards the medicine of the future - more precise, more personalized, more efficient 
MedUni Vienna and the Vienna General Hospital have celebrated the concept for the new Center for Precision Medicine. Donate now to enable construction work to start for this center, which will help to bring the full potential of personalized medicine to society.
Nabriva appoints Gary Sender as Chief Financial Officer 
Prior to joining Nabriva Therapeutics AG, Gary Sender served as Senior Vice President, Finance at Shire plc., and as the founding CFO of Tengion. Before, he held several leadership positions within different departments at Merck, including Investor Relations and M&A Finance. 
Radiology Explorer to win S&B Award at Rudolf Sallinger Fonds
The Science and Business (S&B) Award honors the innovative business concept of Radiology Explorer: with the use of advanced machine learning, visual patterns are used to connect medical images to similar cases, to statistics, and to relevant literature. 
The Antibody Lab: Reliable mammalian cell expression system for bioproduction covered in Biopharma Dealmakers 
The Antibody Lab has launched its proprietary BESTcellTM mammalian cell expression system. The new technology allows generating high productivity clones for customers in a very short time: It only takes 3 weeks from transfection to isolated high productivity clones. 
Vetmeduni Vienna: Drug against breast cancer is also highly potent against a frequent form of leukemia
Researchers at the Vetmeduni Vienna and the German Cancer Research Center (DKFZ) managed to specifically target and kill Acute Myeloid Leukemia (AML) cancer cells carrying a mutation in the FLT3 tyrosine kinase that accelerates the course of the disease.

Read more news at


Web update: 
You can find a review and the seminar material of our Business Meeting at the Lorenz Böhler Emergency Hospital here. Many thanks to the Ludwig Boltzmann Institute for Experimental and Clinical Traumatology for the successful collaboration and to all speakers for their excellent contributions!
Mark your calendar

LISAvienna Business Meeting in cooperation with Fit for Health 2.0: SMEs in Horizon 2020: opportunities and challenges
Vienna, October 17, 2016, 5:30 p.m.
Details about the program and the possibility to register will follow in time.

Optics, Algos and Ice 
Obergurgl, November 17-20, 2016
TissueGnostics symposium on digital microscopy and image analysis and its role in clinical diagnostics and personalized medicine
Abstract submission deadline: June 30, 2016
Meet LISAvienna

Delegation trip life sciences and biotechnology to China and Taiwan
Taipei, Shenzhen, Guangzhou, Shanghai,
August 29 – September 2, 2016
Discuss the event with Jürgen Fuchs and register until June 30, 2016!

9th Annual European Forum for Industrial Biotechnology and the Bioeconomy
Glasgow, October 18-20, 2016

BIO-Europe® 2016
Cologne, November 7-9, 2016
For a reduced fee for participants from Austria please contact Jürgen Fuchs
Latest Publication

The Medical University of Vienna is a hub for innovation. In addition to new treatment options, numerous medical devices are also developed here, often in close collaboration with commercial partners. Chemiereport profiles this resource and presents eight start-ups with close ties to MedUni Vienna. 

More LISAvienna publications are available at

FUNDING and SUPPORT Opportunities

Vienna Business Agency ignites technology development
Three million euros for start-ups

The Vienna Business Agency awards two million euros in the context of the “Start Tech Vienna 2016” funding competition, which focuses on projects by Viennese Start-ups with cutting-edge technology that set trends ahead of their time. Apply by September 14 at!

Another new funding opportunity is the “Vienna Start-up Initiative”. For the first time, newly founded initiatives are sponsored that support Viennese Start-ups. The Vienna Business Agency funds the development and implementation of such innovative services with up to 500,000 euros per project. Apply now at!

OPEN CALLS and DEADLINES to remember

July 8, 2016: WKW - Innovation Award Mercur 2016 
July 27, 2016: FFG – R&D services that allow for an Austrian participation in IEA tasks/annexes (incl. bioenergy) 
August 12, 2016: CDG – CD Laboratories & JR-Centres
September 14, 2016: FFG – Production of the Future: Call 18 and 19: Lead projects on assistive systems in the context of human-machine-cooperation (obligatory preparatory discussion until August 14) and cooperative RTD projects and R&D services (incl. biobased industry and nanomaterials)
September 14, 2016: Vienna Business Agency - Call Start Tech Vienna 2016) 

Register at for a free mailing service on European and other international funding initiatives in the life sciences.
Find additional funding and support opportunities at

EVENTS in Vienna

University of Natural Resources and Life Sciences, Vienna: 25 Years BOKU @ Muthgasse

June 24, 2016, BOKU, Armin Szilvinyi Building, Ground Floor, Aula, Muthgasse 18, 1190 Vienna

QMS Sellemond: GMP Seminar

October 4-6, 2016, Hotel Schani, Karl-Popper-Strasse 22, 1100 Vienna

LBG Meeting For Health Sciences 2016

November 28-29, 2016, Hotel Park Royal Palace Vienna, Schlossallee 8, 1140 Vienna
Deadline for abstract submission: August 31, 2016
For more events be invited to
Your news placed here: Vienna-based organizations are invited to e-mail news and press releases to to contribute to LISAvienna's digital and print media.

Stay updated: Follow us on Twitter and LinkedIn and recommend our e-newsletter to colleagues and friends.
Copyright © LISAvienna 2016, All rights reserved.

Our mailing address is:

LISAvienna is the joint life science platform operated by austria wirtschaftsservice and the Vienna Business Agency. On behalf of the Austrian Federal Ministry of Science, Research and Economy and the city of Vienna, LISAvienna contributes to the advancement of life sciences in Vienna.

unsubscribe from this list  |  update subscription preferences